Dural Graft Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global Dural Graft market is poised for remarkable growth, with a projected valuation of approximately US$ 1300 Million by the end of 2031, up from US$ 799 Million in 2024. This impressive surge can be attributed to a combination of factors, including the rising incidence of neurological disorders, heightened awareness surrounding neurological conditions, and the preference for advanced graft materials.

Rising Incidence of Neurological Disorders and Increasing Awareness about Neurological Conditions

Neurological disorders have become a significant global health concern, contributing substantially to the global disease burden. According to a study published in Frontiers in 2022, neurological disorders resulted in 349 million Disability-Adjusted Life Years (DALYs) and over 10 million fatalities worldwide in 2019. Stroke emerged as the leading cause of DALYs among the 18 neurological illnesses studied.

In recognition of the gravity of this issue, the Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders 2022-2031 was adopted by the 75th World Health Assembly in May 2022. This initiative prioritizes brain health for the next decade, acknowledging that neurological illnesses are the primary cause of disability and the second greatest cause of death globally.

This concerted effort to address neurological disorders, coupled with increased awareness, is driving the growth of the dural graft market.

Increased Preference for Xerographic Dural Grafts and Advanced Dural Graft Material

Many neurosurgeons favor natural and biological source dural grafts, such as xerographic dural grafts, due to their superior patient compatibility and fewer postoperative complications. Next-generation synthetic dural grafts are also expected to gain traction thanks to advancements in material nanotechnology and scientific principles. These bio-absorbable, nanostructured synthetic grafts offer affordability and improved patient comfort, making them a preferred choice among neurosurgeons.

Market Growth Challenges

Despite the promising prospects, the dural graft market faces challenges that could potentially impede its growth. One notable obstacle is the shortage of skilled neurosurgeon workers. The demand for neurosurgeons specializing in dural graft surgeries is high, yet the insufficient availability of qualified personnel results in more than 5 million neurosurgical cases going untreated each year. Furthermore, the overall high cost associated with neurosurgeries, from hospitalization to post-operative care, is expected to slow down market expansion.

Country-wise Insights

Why is the United States Market Booming?

The United States is experiencing significant growth in the dural graft market, primarily driven by an increase in Traumatic Brain Injury (TBI) related deaths. Older individuals in the U.S. are more likely to require hospitalization and succumb to TBIs. This trend is attributed to the similarity of TBI symptoms with other common medical conditions among older adults, such as dementia. The Centers for Disease Control and Prevention estimated that over 64,000 Americans died in 2020 due to TBI, equating to approximately 176 fatalities from TBI per day.

Will China Be a Lucrative Market for Dural Graft?

China is emerging as a lucrative market for dural grafts due to the rising incidence of brain and central nervous system tumors. According to the World Health Organization (WHO), China experienced a significant illness burden in 2020, with 79,575 clinically diagnosed brain and CNS tumor patients and 65,204 fatalities. The growing demand for neurological procedures in China is contributing to the market's expansion.

Competitive Landscape Analysis

Key companies in the dural graft market are focusing on increasing production volume, enhancing their line of neurological surgeries, introducing advanced features, and launching innovative products. Many of these companies are forging strategic partnerships with hospital vendors and physicians to accelerate and improve treatments.

Key Companies Covered

Cook Medical
Integra Lifesciences Corporation
B Braun
Cousin Biotech
Natus Medical Incorporated
Tissuemed Ltd
Vostra Gmbh
Stryker Corporation
Medtronic Plc
Johnson & Johnson
Baxter International Inc

Key Segments Covered in Dural Graft Industry Research

Product:

Xenogeneic Dural Graft
Allogenic Dural Graft
Synthetic Dural Graft
Autologous Dural Graft
Others

Application:

Traumatic Brain and Spine Injury
Cerebrovascular Accident
Cerebrospinal Fluid (CSF) Accumulation
Brain and Spine Tumor
Epilepsy
Others

Material Type:

Bovine Pericardium
Cadaveric Dura
Autologous Pericardium
Synthetic Bovine Collagen Matrix
Ligamentum Nuchae
Others

End User:

Hospitals
Ambulatory Surgical Centers
Trauma Centers
Clinics

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

1. Executive Summary

1.1. Global Dural Graft Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Dural Graft Market Outlook, 2018 - 2031

3.1. Global Dural Graft Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Xenogeneic Dural Graft
  - 3.1.1.2. Allogenic Dural Graft
  - 3.1.1.3. Synthetic Dural Graft
  - 3.1.1.4. Autologous Dural Graft
  - 3.1.1.5. Others
3.2. Global Dural Graft Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Traumatic Brain and Spine Injury
  - 3.2.1.2. Cerebrovascular Accident
  - 3.2.1.3. Cerebrospinal Fluid (CSF) Accumulation
  - 3.2.1.4. Brain and Spine Tumor
  - 3.2.1.5. Epilepsy
  - 3.2.1.6. Others
3.3. Global Dural Graft Market Outlook, by Material Type, Value (US$ Mn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Bovine Pericardium
  - 3.3.1.2. Cadaveric Dura
  - 3.3.1.3. Autologous Pericardium
  - 3.3.1.4. Synthetic Bovine Collagen Matrix
  - 3.3.1.5. Ligamentum Nuchae
  - 3.3.1.6. Others
3.4. Global Dural Graft Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Hospitals
  - 3.4.1.2. Ambulatory Surgical Centers
  - 3.4.1.3. Trauma Centers
  - 3.4.1.4. Clinics
3.5. Global Dural Graft Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America Dural Graft Market Outlook, 2018 - 2031

4.1. North America Dural Graft Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Xenogeneic Dural Graft
  - 4.1.1.2. Allogenic Dural Graft
  - 4.1.1.3. Synthetic Dural Graft
  - 4.1.1.4. Autologous Dural Graft
  - 4.1.1.5. Others
4.2. North America Dural Graft Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Traumatic Brain and Spine Injury
  - 4.2.1.2. Cerebrovascular Accident
  - 4.2.1.3. Cerebrospinal Fluid (CSF) Accumulation
  - 4.2.1.4. Brain and Spine Tumor
  - 4.2.1.5. Epilepsy
  - 4.2.1.6. Others
4.3. North America Dural Graft Market Outlook, by Material Type, Value (US$ Mn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Bovine Pericardium
  - 4.3.1.2. Cadaveric Dura
  - 4.3.1.3. Autologous Pericardium
  - 4.3.1.4. Synthetic Bovine Collagen Matrix
  - 4.3.1.5. Ligamentum Nuchae
  - 4.3.1.6. Others
4.4. North America Dural Graft Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Hospitals
  - 4.4.1.2. Ambulatory Surgical Centers
  - 4.4.1.3. Trauma Centers
  - 4.4.1.4. Clinics
4.5. North America Dural Graft Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 4.5.1.2. U.S. Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 4.5.1.3. U.S. Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 4.5.1.4. U.S. Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 4.5.1.5. Canada Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 4.5.1.6. Canada Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 4.5.1.7. Canada Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 4.5.1.8. Canada Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Dural Graft Market Outlook, 2018 - 2031

5.1. Europe Dural Graft Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Xenogeneic Dural Graft
  - 5.1.1.2. Allogenic Dural Graft
  - 5.1.1.3. Synthetic Dural Graft
  - 5.1.1.4. Autologous Dural Graft
  - 5.1.1.5. Others
5.2. Europe Dural Graft Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Traumatic Brain and Spine Injury
  - 5.2.1.2. Cerebrovascular Accident
  - 5.2.1.3. Cerebrospinal Fluid (CSF) Accumulation
  - 5.2.1.4. Brain and Spine Tumor
  - 5.2.1.5. Epilepsy
  - 5.2.1.6. Others
5.3. Europe Dural Graft Market Outlook, by Material Type, Value (US$ Mn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Bovine Pericardium
  - 5.3.1.2. Cadaveric Dura
  - 5.3.1.3. Autologous Pericardium
  - 5.3.1.4. Synthetic Bovine Collagen Matrix
  - 5.3.1.5. Ligamentum Nuchae
  - 5.3.1.6. Others
5.4. Europe Dural Graft Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Hospitals
  - 5.4.1.2. Ambulatory Surgical Centers
  - 5.4.1.3. Trauma Centers
  - 5.4.1.4. Clinics
5.5. Europe Dural Graft Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.5.1.2. Germany Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.3. Germany Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.4. Germany Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.5. U.K. Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.5.1.6. U.K. Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.7. U.K. Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.8. U.K. Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.9. France Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.5.1.10. France Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.11. France Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.12. France Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.13. Italy Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.5.1.14. Italy Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.15. Italy Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.16. Italy Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.17. Turkey Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.5.1.18. Turkey Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.19. Turkey Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.20. Turkey Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.21. Russia Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.5.1.22. Russia Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.23. Russia Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.24. Russia Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.25. Rest of Europe Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.5.1.26. Rest of Europe Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.27. Rest of Europe Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.28. Rest of Europe Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Dural Graft Market Outlook, 2018 - 2031

6.1. Asia Pacific Dural Graft Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Xenogeneic Dural Graft
  - 6.1.1.2. Allogenic Dural Graft
  - 6.1.1.3. Synthetic Dural Graft
  - 6.1.1.4. Autologous Dural Graft
  - 6.1.1.5. Others
6.2. Asia Pacific Dural Graft Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Traumatic Brain and Spine Injury
  - 6.2.1.2. Cerebrovascular Accident
  - 6.2.1.3. Cerebrospinal Fluid (CSF) Accumulation
  - 6.2.1.4. Brain and Spine Tumor
  - 6.2.1.5. Epilepsy
  - 6.2.1.6. Others
6.3. Asia Pacific Dural Graft Market Outlook, by Material Type, Value (US$ Mn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Bovine Pericardium
  - 6.3.1.2. Cadaveric Dura
  - 6.3.1.3. Autologous Pericardium
  - 6.3.1.4. Synthetic Bovine Collagen Matrix
  - 6.3.1.5. Ligamentum Nuchae
  - 6.3.1.6. Others
6.4. Asia Pacific Dural Graft Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Hospitals
  - 6.4.1.2. Ambulatory Surgical Centers
  - 6.4.1.3. Trauma Centers
  - 6.4.1.4. Clinics
6.5. Asia Pacific Dural Graft Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. China Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 6.5.1.2. China Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.5.1.3. China Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.4. China Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.5. Japan Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 6.5.1.6. Japan Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.5.1.7. Japan Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.8. Japan Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.9. South Korea Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 6.5.1.10. South Korea Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.5.1.11. South Korea Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.12. South Korea Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.13. India Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 6.5.1.14. India Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.5.1.15. India Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.16. India Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.17. Southeast Asia Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 6.5.1.18. Southeast Asia Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.5.1.19. Southeast Asia Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.20. Southeast Asia Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.21. Rest of Asia Pacific Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 6.5.1.22. Rest of Asia Pacific Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.5.1.23. Rest of Asia Pacific Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.24. Rest of Asia Pacific Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Dural Graft Market Outlook, 2018 - 2031

7.1. Latin America Dural Graft Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Xenogeneic Dural Graft
  - 7.1.1.2. Allogenic Dural Graft
  - 7.1.1.3. Synthetic Dural Graft
  - 7.1.1.4. Autologous Dural Graft
  - 7.1.1.5. Others
7.2. Latin America Dural Graft Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
7.3. Latin America Dural Graft Market Outlook, by Material Type, Value (US$ Mn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Bovine Pericardium
  - 7.3.1.2. Cadaveric Dura
  - 7.3.1.3. Autologous Pericardium
  - 7.3.1.4. Synthetic Bovine Collagen Matrix
  - 7.3.1.5. Ligamentum Nuchae
  - 7.3.1.6. Others
7.4. Latin America Dural Graft Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Hospitals
  - 7.4.1.2. Ambulatory Surgical Centers
  - 7.4.1.3. Trauma Centers
  - 7.4.1.4. Clinics
7.5. Latin America Dural Graft Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 7.5.1.2. Brazil Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 7.5.1.3. Brazil Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 7.5.1.4. Brazil Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 7.5.1.5. Mexico Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 7.5.1.6. Mexico Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 7.5.1.7. Mexico Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 7.5.1.8. Mexico Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 7.5.1.9. Argentina Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 7.5.1.10. Argentina Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 7.5.1.11. Argentina Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 7.5.1.12. Argentina Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 7.5.1.13. Rest of Latin America Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 7.5.1.14. Rest of Latin America Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 7.5.1.15. Rest of Latin America Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 7.5.1.16. Rest of Latin America Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Dural Graft Market Outlook, 2018 - 2031

8.1. Middle East & Africa Dural Graft Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Xenogeneic Dural Graft
  - 8.1.1.2. Allogenic Dural Graft
  - 8.1.1.3. Synthetic Dural Graft
  - 8.1.1.4. Autologous Dural Graft
  - 8.1.1.5. Others
8.2. Middle East & Africa Dural Graft Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Traumatic Brain and Spine Injury
  - 8.2.1.2. Cerebrovascular Accident
  - 8.2.1.3. Cerebrospinal Fluid (CSF) Accumulation
  - 8.2.1.4. Brain and Spine Tumor
  - 8.2.1.5. Epilepsy
  - 8.2.1.6. Others
8.3. Middle East & Africa Dural Graft Market Outlook, by Material Type, Value (US$ Mn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Bovine Pericardium
  - 8.3.1.2. Cadaveric Dura
  - 8.3.1.3. Autologous Pericardium
  - 8.3.1.4. Synthetic Bovine Collagen Matrix
  - 8.3.1.5. Ligamentum Nuchae
  - 8.3.1.6. Others
8.4. Middle East & Africa Dural Graft Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Hospitals
  - 8.4.1.2. Ambulatory Surgical Centers
  - 8.4.1.3. Trauma Centers
  - 8.4.1.4. Clinics
8.5. Middle East & Africa Dural Graft Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 8.5.1.2. GCC Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.5.1.3. GCC Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.4. GCC Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.5.1.5. South Africa Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 8.5.1.6. South Africa Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.5.1.7. South Africa Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.8. South Africa Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.5.1.9. Egypt Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 8.5.1.10. Egypt Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.5.1.11. Egypt Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.12. Egypt Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.5.1.13. Nigeria Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 8.5.1.14. Nigeria Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.5.1.15. Nigeria Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.16. Nigeria Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.5.1.17. Rest of Middle East & Africa Dural Graft Market by Product, Value (US$ Mn), 2018 - 2031
  - 8.5.1.18. Rest of Middle East & Africa Dural Graft Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.5.1.19. Rest of Middle East & Africa Dural Graft Market by Material Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.20. Rest of Middle East & Africa Dural Graft Market by End User, Value (US$ Mn), 2018 - 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Product vs Application Heatmap
9.2. Manufacturer vs Indication Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Cook Medical
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Integra Lifesciences Corporation
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. B Braun
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Cousin Biotech
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Natus Medical Incorporated
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. Tissuemed Ltd
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Vostra Gmbh
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. Stryker Corporation
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. Medtronic Plc
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations